| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5876565 | The American Journal of Medicine | 2012 | 7 Pages |
Abstract
Prophylactic C1INH-nf is highly effective and safe, and provides durable prophylaxis in the majority of patients with hereditary angioedema. The recommended dose of C1INH-nf 1000 units twice weekly is supported by this open-label study. Individual patients may benefit from further dose adjustment on the basis of response to therapy and individual treatment goals.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Bruce L. MD, Ira MD,